New York, NY 10011

Smarter Clinical Pharmacology for Faster Drug Development

Offering Professional Assistance for Your Drug Development Needs

From Data to Decisions - Clinical Pharmacology That Drives Development Forward

At XP Pharma Consulting, we apply clinical pharmacology-guided and model-informed strategies to streamline every stage of drug development through registration. Our work combines advanced pharmacokinetics (PK), pharmacodynamics (PD), and pharmacometrics to deepen understanding of drug behavior - empowering our clients to make faster, data-driven decisions and bring essential medicines to patients sooner.

ABOUT US

Guiding Your Program at Every Stage of Development

We act as an extension of your clinical pharmacology team combining scientific precision with strategic insight to accelerate every stage of your program. Whether you're preparing for your first-in-human study or optimizing your NDA submission, XP Pharma supports your program with the right pharmacology expertise at every milestone.

  • Accelerate development timelines through optimized PK/PD modeling
  • Reduce regulatory risk with model-informed dosing strategies and submission-ready analyses
  • Support every phase-from First-in-Human to Phase III and beyond
  • Integrate seamlessly with your existing clinical and biostatistics teams
[sp_easyaccordion id="1630"]

Explore Our Core Service Areas

Clinical Pharmacology bridges the science of drug discovery with the realities of patient treatment. It explores how drugs interact with the human body - encompassing mechanism of action, formulation development, absorption, distribution, metabolism, and excretion (ADME), pharmacokinetics (PK), pharmacodynamics (PD), drug-drug interactions (DDI), safety, and efficacy.


The ultimate goal is simple yet critical: to ensure the right dose reaches the right patient at the right time. By integrating quantitative methodologies - including noncompartmental analysis (NCA), pharmacometrics, and model-informed strategies — within the framework of current regulatory expectations, Clinical Pharmacology enables more efficient, evidence-based drug development.

XP Pharma Consulting provides comprehensive Clinical Pharmacology services spanning:

  • • Clinical Pharmacology Studies
  • • Noncompartmental PK Analysis (NCA)
  • • Pharmacometrics and Modeling
  • • Clinical Pharmacology Strategy & Regulatory Writing

Explore the sections below for detailed deliverables at each stage of development.

Clinical Pharmacology Studies

Protocol design, PK/PD integration, and study oversight for various types of clinical pharmacology studies LEARN MORE

Noncompartmental PK Analysis (NCA)

End-to-end support for NCA PK analysis, results interpretation, and submission-ready reports LEARN MORE

Pharmacometrics (PK/PD Modeling)

End-to-end PK/PD modeling support to enable model-informed drug development (MIDD) across all phases LEARN MORE

Clinical Pharmacology Strategy and Writing

End-to-end strategy development and regulatory writing for IND/NDA/BLA submission LEARN MORE

Expertise and experience

17+

NDA/BLA (CTD 2.7.1 and 2.7.2 and Sections of Other CTD Modules)

100+

NCA PK, Exposure-Response Analysis, Reports

30+

Population PK Modeling, Reports

22+

Population PK/PD Modeling, Reports

86+

Clinical Study Protocols

80+

Clinical Study Reports

35+

Clinical Pharmacology Strategy, Plans

26+

TQT and DDI Study Waivers

Testimonials

Population PK/PD Modeling & Simulation

XP Pharma played a significant role in supporting the early clinical development programs. Their PK assessments, modeling & simulation offered important information to determine safe and optimal dosing regimens for our Phase 1 and Phase 2 clinical trials.

Executive Director - Clinical Development

Clinical Pharmacology Studies

XP Pharma Consulting's knowledge of FDA requirements around clinical pharmacology (drug-drug interaction studies, CYP450 interaction studies) has helped us to design our clinical pharmacology plans effectively by allowing us to incorporate NDA-required studies optimally.

Executive Director - Clinical Development

Leading Edge Pharmacology Support

XP Pharma provided leading-edge clinical pharmacology advice and services that led to several successful IND approvals. They have assisted us on translational research programs at the pre-IND to IND stage using PK/PD modeling and simulation.

Director - Clinical Development

Clinical Pharmacology Strategy and Writing

XP Pharma can manage all aspects of clinical pharmacology projects. XP Pharma assessed DDI potential, risk of QT prolongation potential, designed clinical pharmacology studies, and authored TQT waiver applications, CTD 2.7.2 and CTD 2.7.2, and responses to regulatory questions.

Sr. Director - Clinical Pharmacology

XP Pharma Consulting

Reasons to Partner with XP Pharma Consulting

At XP Pharma Consulting, we combine deep expertise in clinical pharmacology, pharmacokinetics, and pharmacometrics to accelerate and strengthen your drug development program. Our consultants integrate seamlessly with your internal teams, applying rigorous quantitative approaches, validated computation methodologies, and regulatory insight to support every stage of development—from first-in-human studies through NDA and BLA submissions.

We go beyond delivering analyses to provide strategic interpretation—ensuring that every dataset informs sound clinical decisions and supports regulatory success. With a proven track record of high-quality deliverables and trusted partnerships across biotech and pharmaceutical organizations, XP Pharma Consulting is committed to helping you move forward with confidence.

Let’s collaborate to advance your therapeutic vision to patients faster—through clarity, precision, and scientific excellence.

View Case Studies

Achieve Regulatory Approval With Our Help

The path to regulatory approval is full of pitfalls and sometimes, organizations need some help navigating the regulatory environment. Our experience can guide you through that sometimes-complicated process and help you to design a program to investigate and determine the pharmacokinetics (PK) and pharmacodynamics (PD) of your drug. XP Pharma Consulting works with your team to aid informed decision-making and avoid regulatory rejection by facilitating a solid understanding of your drug’s PK and PD properties and PK exposure-response relationships.

XP Pharma Consulting’s Record of Success

Contributed to more than 140 clinical studies in the following therapeutic areas:

Analgesia, anesthesia, cardiovascular, central nervous system, hematology, infectious disease, metabolic and endocrine disorders, oncology, pediatrics, pulmonary, rare genetic diseases, and rheumatology

Completed more than 60 clinical pharmacology studies, including

Bioequivalence, drug-drug Interaction, food effect, multiple ascending doses, radio-labeled mass balance, single ascending dose, special population, and thorough QT studies

Contributed to the clinical development of more than 61 drugs, including

Small molecules, large molecules, RNA/RNAi-based therapies, mRNA-based therapies, CRISPR-based genome editing therapies, and enzyme replacement therapies

Contributed to the authorship of more than 355 regulatory documents

address

New York, NY 10011

send us a message

[wpforms id="1196" title="false"]